Migraine-specific Preventive Therapies Can Be a Primary Care Tool, Leading Investigator Says
Migraine-specific preventive therapies should be in the primary care toolbox, according to headache specialist Jessica Ailani, MD.
"These newer [migraine] therapies are geared for primary care. Their side effect profile is fantastic...they're easy to use...and primary care providers are very comfortable with monoclonal antibodies," said migraine specialist and researcher Jessica Ailani, MD, while speaking with Patient Care.
In the rest of our conversation, captured below, Ailani discussed the remarkable results some migraine patients are experiencing with the calcitonin gene-related peptide inhibitors and other new targeted drug classes as well as the opportunities for effective primary care-specialist cotreatment.
Jessica Ailani, MD, is professor of clinical neurology and director of Medstar Georgetown Headache Center at the MedStar Georgetown University Hospital in Washington, DC.
The CMS CED Policy Limits Treatment for Early Alzheimer's Disease: What It Is and How It Works
December 16th 2024The coverage with evidence development (CED) policy requires enrollment in an active clinical trial for an adult to be eligible for Medicare coverage of treatment for Alzheimer's disease.
